VESAMICOL ANALOGS AS SIGMA-LIGANDS - MOLECULAR DETERMINANTS OF SELECTIVITY AT THE VESAMICOL RECEPTOR

被引:71
作者
EFANGE, SMN
MACH, RH
SMITH, CR
KHARE, AB
FOULON, C
AKELLA, SK
CHILDERS, SR
PARSONS, SM
机构
[1] UNIV MINNESOTA,DEPT RADIOL,MINNEAPOLIS,MN 55455
[2] UNIV MINNESOTA,DEPT MED CHEM,MINNEAPOLIS,MN 55455
[3] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT RADIOL,WINSTON SALEM,NC 27157
[4] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT PHYSIOL & PHARMACOL,WINSTON SALEM,NC 27157
[5] UNIV CALIF SANTA BARBARA,DEPT CHEM,SANTA BARBARA,CA 93106
关键词
ACETYLCHOLINE TRANSPORT; VESAMICOL RECEPTOR; VESAMICOL ANALOGS; SIGMA RECEPTOR; SELECTIVITY;
D O I
10.1016/0006-2952(94)00541-S
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study compares the affinities of 2-(4-phenylpiperidino)cyclohexanol (vesamicol, 1) and selected analogues of the latter at the vesamicol receptor (VR) with the corresponding affinities at sigma 1 and sigma 2 binding sites. For this study, the parent structure 1 was divided into three fragments: A (cyclohexyl), B (piperidyl) and C (phenyl). Vesamicol analogues were then selected to reflect structural modifications in these fragments. Consistent with earlier reports, vesamicol was found to exhibit nanomolar affinities at the VR and sigma 1 and sigma 2 sites, resulting in poor selectivity for the VR over the sigma sites. Vesamicol analogues characterized by an acyclic A-fragment showed moderate to low affinities at the VR and moderate to high affinities at sigma 1 and sigma 2 sites. As a result, many of these analogues showed poor selectivity for the VR. Replacement of the C4 carbon of 1 with a halobenzyl amine resulted in higher affinities at the VR coupled with moderate to low affinities at sigma 1 and sigma 2 sites. The introduction of a benzofused substituent at the C4 and C5 positions of 1 (compound 2) resulted in a 200-fold increase in affinity at the VR accompanied by a 5- to 6-fold decrease in affinity at sigma 1 and sigma 2 sites relative to the parent structure. Consequently, compound 2 showed 12,000-fold higher affinity at the VR than at sigma sites. Restricting the rotation of fragment C relative to B (by means of alkyl and alkenyl bridges) generally yielded analogues with subnanomolar affinities at the VR. The corresponding affinities of these spirofused conformationally restricted analogues were moderate to poor at sigma 1 and sigma 2 sites when fragment A was preserved. In contrast, the affinities at sigma 1 and sigma 2 sites were decreased 3- to 11-fold when fragment A was modified at position C4 and decreased up to 100-fold with benzofusion at the C4 and C5 positions of fragment A. Consequently, the spirofused analogues 15-19 were among the most selective VR ligands examined. Thus, the effect of conformational restriction in fragments A and B-C is to increase affinity at the VR while decreasing affinity at sigma 1 and sigma 2 sites, and thereby increasing selectivity for the VR over the sigma sites.
引用
收藏
页码:791 / 797
页数:7
相关论文
共 32 条
[1]   [H-3] VESAMICOL BINDING IN BRAIN - AUTORADIOGRAPHIC DISTRIBUTION, PHARMACOLOGY, AND EFFECTS OF CHOLINERGIC LESIONS [J].
ALTAR, CA ;
MARIEN, MR .
SYNAPSE, 1988, 2 (05) :486-493
[2]   DEMONSTRATION OF A RECEPTOR IN TORPEDO SYNAPTIC VESICLES FOR THE ACETYLCHOLINE STORAGE BLOCKER L-TRANS-2-(4-PHENYL[3,4-H-3]-PIPERIDINO)CYCLOHEXANOL [J].
BAHR, BA ;
PARSONS, SM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (07) :2267-2270
[3]   EVIDENCE FOR A MULTI-SITE MODEL OF THE RAT-BRAIN SIGMA-RECEPTOR [J].
BOWEN, WD ;
HELLEWELL, SB ;
MCGARRY, KA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 163 (2-3) :309-318
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   NEUROMUSCULAR BLOCKING ACTION OF 2-(4-PHENYLPIPERIDINO) CYCLOHEXANOL (AH 5183) [J].
BRITTAIN, RT ;
LEVY, GP ;
TYERS, MB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1969, 8 (01) :93-&
[6]  
BRITTAIN RT, 1969, BRIT J PHARMACOL, V36, pP173
[7]   THE EFFECT OF THE ACETYLCHOLINE TRANSPORT BLOCKER VESAMICOL ON CENTRAL CHOLINERGIC PRESSOR NEURONS [J].
BUCCAFUSCO, JJ ;
WEI, J ;
KRAFT, KL .
SYNAPSE, 1991, 8 (04) :301-306
[8]  
CHENG YC, 1973, BIOCHEM PHARMACOL, V22, P3009
[9]  
Efange S. M., 1992, J LABELLED COMPD RAD, V32, P311
[10]   SYNTHESIS AND TISSUE DISTRIBUTION OF (M-[I-125]IODOBENZYL)TROZAMICOL ([I-125]MIBT) - POTENTIAL RADIOLIGAND FOR MAPPING CENTRAL CHOLINERGIC INNERVATION [J].
EFANGE, SMN ;
MICHELSON, RH ;
KHARE, AB ;
THOMAS, JR .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (12) :1754-1760